View More Recent Stories

Mar 19, 2025 07:45AM Roivant Sciences (ROIV) Announces Positive Results for Batoclimab Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy Studies
Mar 3, 2025 09:15AM Genevant Sciences (ROIV) and Arbutus Biopharma (ABUS) Initiate International Patent Infringement Enforcement Actions Against Moderna
Feb 10, 2025 07:24AM Roivant Sciences Ltd. (ROIV) Tops Q3 EPS by 48c
Jan 17, 2025 03:31PM Roivant Sciences (ROIV) 30K contracts of January 15 2026 calls
Jan 13, 2025 05:32AM Increasing unusual option volume: EIX INVZ ROIV PCG CHAU NVT SENS OPFI GRRR HPP
Jan 10, 2025 03:43PM Roivant Sciences (ROIV) spreader of 15K contracts of February 10 puts and February 11 calls
Nov 30, 2024 10:00PM JPMorgan is out with its 2025 outlook for biotech stocks
Nov 12, 2024 04:26PM Roivant Sciences Ltd. (ROIV) Misses Q2 EPS by 2c
Oct 28, 2024 09:25AM Organon (OGN) Completes Acquisition of Dermavant
Oct 21, 2024 05:58AM Leerink Partners Reiterates Outperform Rating on Roivant Sciences (ROIV)
Oct 16, 2024 06:15AM JPMorgan Reiterates Overweight Rating on Roivant Sciences (ROIV), 'ROIV is on the Analyst Focus List'
Sep 24, 2024 02:55PM Roivant Sciences (ROIV) 5K contracts of October 12 calls trade
Sep 19, 2024 08:11AM Goldman Sachs Reiterates Buy Rating on Roivant Sciences (ROIV)
Sep 19, 2024 06:44AM H.C. Wainwright Reiterates Buy Rating on Roivant Sciences (ROIV)
Sep 18, 2024 11:56AM TD Cowen Reiterates Buy Rating on Roivant Sciences (ROIV)
Sep 18, 2024 07:30AM Organon (OGN) to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA Cream, 1%
Sep 11, 2024 08:59AM TD Cowen Reiterates Buy Rating on Roivant Sciences (ROIV)
Sep 11, 2024 06:36AM H.C. Wainwright Reiterates Buy Rating on Roivant Sciences (ROIV)
Sep 11, 2024 05:18AM Roivant Sciences (ROIV) PT Raised to $12.50 at BofA Securities
Sep 10, 2024 06:32AM Roivant Sciences (ROIV) Unveils New Pipeline Program Mosliciguat
Sep 10, 2024 06:31AM Roivant Sciences (ROIV) presents positive proof-of-concept data from the Phase 1b ATMOS study of Mosliciguat
Sep 9, 2024 07:02AM Roivant Sciences (ROIV) Provides Update on Graves’ Disease Development Program
Sep 3, 2024 10:46AM Increasing unusual call option volume: ROIV NEXT URBN DG SBLK NCNO GPRE CAMT VUZI
Aug 26, 2024 06:19AM Increasing unusual option volume: ROIV GLNG PTEN DINO NBR NGD PRGO
Aug 19, 2024 06:49AM H.C. Wainwright Reiterates Buy Rating on Roivant Sciences (ROIV)
Aug 8, 2024 03:05PM Roivant Sciences (ROIV) spreaders active in September 10 puts, September 11 and 12 calls
Aug 8, 2024 07:45AM Roivant Sciences Ltd. (ROIV) Tops Q1 EPS by 36c
Jul 18, 2024 07:47AM Piper Sandler Reiterates Overweight Rating on Roivant Sciences (ROIV)
Jul 10, 2024 06:41AM Roivant Sciences (ROIV) PT Raised to $22 at Piper Sandler
View More Recent Stories